This study uses international survey and transplant registry data to compare use of bone marrow with use of peripheral blood stem cells for hematopoietic stem cell transplantation in World Health Organization member countries.
This randomized clinical trial evaluates the effect of autologous hematopoietic stem cell transplantation on sustained disease remission among patients with refractory Crohn disease.
This study found that longer donor leukocyte telomere length was associated with increased 5-year survival for patients with severe aplastic anemia who had undergone a hematopoietic cell transplant.
In this single-center study of patients with relapsing-remitting multiple sclerosis, nonmyeloablative hematopoietic stem cell transplantation was associated with improvement in neurological disability and other clinical outcomes.
In a trial involving 30 adult patients with sickle cell phenotype with or without thalassemia, Hsieh and coauthors report that after undergoing nonmyeloablative allogeneic hematopoietic stem cell transplantation from human leukocyte antigen–matched siblings, 26 patients achieved long-term engraftment.